Summary: Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to. a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids.
Introduction
In the autumn of 1965 a systematic long-range study of uterine cervical carcinoma in women using contraceptives was begun by Planned Parenthood of New York City, Inc., in conjunction with the Memorial Hospital for Cancer and Allied Diseases and the Sloan-Kettering Institute for Cancer Research. The study was designed primarily to determine whether various forms of contraceptives exert any influence on the development of cervical carcinoma. Two major statistical evaluations were proposed. The first, based on prevalence rates of the disease as found in an initial survey, was to compare matched populations of women who had been using the diaphragm with women using oral steroids. The second was planned as an incidence study of cervical carcinoma and related epithelial abnormalities as they develop in matched populations that are initially found to be free of the disease and are using the diaphragm, an intrauterine device, or oral steroids. The study of incidence rates will require several more years before it is complete. This report is concerned with an analysis of the prevalence rates.
Data Collection
The prevalence rates are for clinically occult cervical carcinomas and, except for a single case, they were all carcinomas in situ or carcinomas in situ with micofocal invasion. They were detected by cytology and confirmed by cervical biopsy or conization. Overt carcinoma of the uterine cervix was not found in this population, probably because of three factors: (1) this is a generally young population who would not be expected to have advanced disease, (2) the virtual absence of women with advanced cervical carcinoma probably reflects the effect of cancer screening programmes on the general population attending many different health facilities in New York City, and (3) it is probable that women with symptoms seek medical attention at hospitals or physicians' offices and do not think of Planned Parenthood centres as a treatment facility.
Routine annual examinations of cervical and vaginal cytology specimens were begun on all women at the onset of this study in October 1965, and the initial cytological screening was completed by July 1967. Previous to that cytological screening at Planned Parenthood centres had been performed routinely only for those women who wished to wear an intrauterine device. For this reason the analysis of prevalence rate data could not include the latter group. Only those women using the diaphragm and those using oral steroids for contraception were compared.
Collection of Cytology Specimens
The cytology specimens were obtained with cotton-tipped applicators, one from the cervix and endocervix and another from the vaginal pool; each was smeared on a separate glass slide and both slides were fixed immediately in 95% ethyl alcohol. The slides were taken by messenger to the Memorial Hospital, where they were stained, screened, and evaluated under the direction of two of us (M. R. M. and L. G. K.). Reports of the examination were mailed back to the centre.
Collection of Clinical Data
Clinical data necessary for this study, including a detailed record of the contraceptive method(s) used, were taken from each woman's chart at the Planned Parenthood centre when the cytology specimen was collected. In the case of new patients this information was contained in answers to specific questions on an initial history form that was filled in by trained interviewers who see each new applicant. This form also contains the examining physician's notes and prescription or recommendation, and a carbon copy accompanies the cytology specimen.
In the case of women who had been attending the centre before the start of the study an abstract was prepared from their chart and from a special supplemental question form filled in by the interviewer when the first cytology specimen was taken. For all of the women subsequent cytology specimens were always accompanied by a carbon copy of the interval notes that had been recorded in the chart.
Questions were included concerning five factors that were chosen as the most reliable and most important of those known to influence the prevalence rate of cervical carcinoma: age, ethnic origin, age at first pregnancy (as a reflection of early sexual experience), number of children born alive (as a reflection of the number of pregnancies), and net weekly family income (as a reflection of socioeconomic status) (Lombard and Potter, 1950; Wynder et al., 1954; Jones et al., 1958 ; Haenszel and Hillhouse, 1959; Terris and Oalmann, 1960; Rotkin, 1962; Rotkin and King, 1962; Boyd and Doll, 1964; Christopherson and Parker, 1965 
Criteria for Selection of Determinant Cases
In order to achieve prevalence rates as nearly accurate as possible the following criteria were established.
Total Population
All women who had been examined at least once in one of the centres of Planned Parenthood and had had a technically satisfactory cytological specimen taken and submitted for our examination, with complete clinical data, were included in the study. Fewer than 25 cases from over 40,000 originally entered were excluded because of incomplete information; 450 were excluded because the initial cytological specimen was unsatisfactory and the women failed to return.
Of the remaining 39,954 women, 27,508 selected oral steroids for contraception and 6,809 selected the diaphragm. This analysis is concerned with the 34,317 women in these two groups.
For reasons explained above, the intrauterine device users could not be included in this prevalence study but will be considered in subsequent incidence studies. There were too few women choosing other methods (condom, foam, etc.) to warrant their inclusion (Dubrow et al., 1969 Our criteria for the cytological diagnoses and for the histological diagnoses of carcinoma, carcinoma in situ, and related lesions, based on a long prospective study of this disease, have been described in detail and amply illustrated in previous publications (Koss et ad., 1963 ; Koss, 1968) . We are aware that some of the lesions we diagnose as carcinoma in situ may be named " precancerous metaplasia," " anaplasia," " dysplasia," "atypical hyperplasia," " significant epithelial abnormality," " cervical intraepithelial neoplasia," and a variety of other terms by some other pathologists. Any of these lesions may be precursors of invasive cervical carcinoma, and though there is controversy about which particular patient with which particular lesion will develop invasive cervical carcinoma, and when-something we cannot predict-there is evidence that invasive carcinoma can be prevented if all women with these precursor lesions are treated (Marshall, 1965) .
All cytological and histological examinations were performed without referral to clinical data collected for statistical evaluation and without knowledge of the contraceptive used or contemplated.
Methods of Data Analysis
The initial data analysis compares prevalence rates of carcinoma in situ (including carcinoma in situ with microfocal invasion and the one case of clinically occult invasive carcinoma) in all of the women choosing and using diaphragms with those choosing and using oral steroids, according to documented minimum duration of use.
Then, for women using these contraceptive methods for at least one year, prevalence rates are compared according to each of the five factors that were selected because of their known influence on the rate of the disease. As previously noted, these are age, ethnic origin, age at first pregnancy, number of children born alive, and net family income.
Finally, in order to eliminate bias which might be introduced by the known association between these five factors and the method of contraceptive chosen (Dubrow et al., 1969) The higher prevalence rates of carcinoma in situ2 among steroid users is not explained by a difference in age between them and the women using diaphragms; in fact, the women using steroids are generally younger than those using the diaphragm (Dubrow et al., 1969) . Age-specific prevalence rates are given in Table II of women who are known to have been using their respective contraceptives for a minimum of at least one year previous to the initial cytological examination. Similar comparisons can be drawn between the women using diaphragms and those who use oral steroids, according to ethnic origin (Table III) , age at first pregnancy (Table IV) , number of children (Tables IV  and V) , and net family income (Table VI) . In all, there is consistently a higher prevalence rate of carcinoma in situ among the women who chose and used oral steroids for contraception compared with those who chose and used the diaphragm. It is obviously desirable to correct simultaneously for as many of the known factors influencing the prevalence of this disease as is possible, particularly because these factors are themselves interrelated in varying ways. This was done by the method of vector assignments to each patient, as already described, randomly matching individual patients with identical vectors by computer. As in the previous tables, the women who are matched have all been using their respective contraceptive methods for a minimum of one year. Again, it must be emphasized that the prevalence rates of carcinoma in situ are determined by the number of women with the disease who t Positive pairs, triplets, or quadruplets refers to a matched group of women that includes onewith carcinoma in situ. In two separate instances, two women with carcinoma in situ fell into one quadruplet; in both cases the two women were steroid users and each quadruplet was counted as one.
t Diaphragm positive pairs, triplets, or quadruplets refers to matched groups in which the patient with carcinoma in situ was using a diaphragm; steroid positive pairs, triplets or quadruplets refers to matched groups in which the patient with carcinoma in situ used steroids.
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had cytological evidence of it on entering the study, and subsequent histological confirmation by cervical biopsy or conization. The results of these matched comparisons are indicated in Table VII , for ratios of diaphragm users to steroid users of 1:1, 1:2, and 1:3.
The three different ratios were investigated because the number of women from each group that can be matched varies according to the ratio. The overall number of women using steroids longer than one year is nearly twice the number using a diaphragm for a similar minimum period, hence the 1: 2 ratio seems most reasonable. The diaphragm users, however, tend to be older than the women using steroids (Dubrow et al., 1969) , and many of the older women using diaphragms and younger women using steroids cannot be matched at a 1:2 ratio. Matching at the additional ratio of 1: 1 included more of the older women using diaphragms; and matching at a ratio of 1: 3 included more of the younger women using steroids (Table VIII) . At all ratios a consistently higher prevalence rate for cervical carcinoma in situ was found among the steroid users (Table VII) . The reason for the difference in prevalence rates is not clear. One could postulate some still unknown factor(s) in the makeup, behaviour, or habits of a woman that would alter her probability of developing cervical carcinoma and at the same time impel her to choose a particular contraceptive.
In several different studies a lower rate of cervical carcinoma was found for women who had used barrier contraceptives (diaphragm or condom), compared with women using no contraceptive (Terris and Oalmann, 1960; Boyd and Doll, 1964; Aitken-Swan and Baird, 1965) . Though not confirmed by all investigators (Lombard and Potter, 1950 ; Wynder et al., 1954; Jones et al., 1958; Rotkin and King, 1962) , this finding, if true, could well account for the differences we found. Experimental animal studies can be cited to show that human smegma is carcinogenic in susceptible mice (Pratt-Thomas et al., 1956 ), thus providing a rationale for the concept that barrier contraceptives such as the diaphragm and condom are protective. Also, there is an increased rate of cervical carcinoma in prostitutes (R0jel, 1953) , an increased frequency of coitus among women who develop cervical carcinoma (Terris and Oalmann, 1960; Boyd and Doll, 1964) , an increased probability of carcinoma in women who first experience coitus at an early age (Rotkin, 1962) , and virtually no cervical carcinoma in nuns (Gagnon, 1950) .
On the other hand, the cervicovaginal epithelium is a known target organ for steroids, and it is considerably altered by oestrogens and progestogens (Taylor et al., 1967; Koss, 1968) .
There is experimental evidence that prolonged administration of large doses of oestrogens can cause uterine cervical carcinoma in mice (Allen and Gardner, 1941) . The constancy of prevalence rates in Table I does not suggest that we are seeing this kind of direct hormonal effect, but it must be remembered that the data in Table I are not corrected for any of the known factors that affect prevalence rates of this disease. Table I must not be interpreted as giving incidence rate information, since it results from initial examinations only (as is true of all data in this report), and there is a presumed loss of some cases due to diagnosis and treatment elsewhere. The opportunity for loss of this kind increases with increasing time in attendance at the centre previous to the initiation of this study, and would be expected to mask any trend in Table I. A study of the incidence rates of uterine cervical carcinoma in matched populations of women using various contraceptives is now in progress and should help to clarify some of the questions raised. First, it is essential that the differences noted in prevalence rates be confirmed by incidence rates before we can be entirely sure that these differences are not artifactitious. Data from the population of women who are wearing an intrauterine device will be particularly useful, since there is neither a barrier effect nor a hormonal effect with this particular contraceptive.
Clearly, the long-term well-being of many women is involved in these questions, and the health of women attending centres of Planned Parenthood of New York City has been of primary concern to us. During the course of this study every effort has been made to find and treat the women with cervical carcinoma or carcinoma in situ and related epithelial abnormalities while the lesions are still early enough to be cured in 100% of the cases. All women attending centres of Planned Parenthood are assured of prompt and proper treatment, regardless of choice of contraceptive. Preliminary data from centres of Planned Parenthood, unrelated 
Introduction
Most follow-up studies of patients treated by thyroidectomy make reference to the incidence of recurrence of thyrotoxicosis after operation. The prognosis for such relapsed patients with reference to subsequent morbidity and to the effectiveness of subsequent treatment is, however, uncertain. This study describes the results of treatment in 90 patients who relapsed after thyroidectomy. In this situation the results of treatment by drugs and surgery are very different from those of treatment of the first episode.
Methods
Ninety patients (77 (85 6%) female and 13 (14 4%) male) who had been treated by thyroidectomy for thyrotoxicosis and who had subsequently relapsed were reviewed. The age distribution of the patients at the time of operation is shown in Table I The time of relapse of thyrotoxicosis following the initial operation is shown in Fig. 1 
